New Key Statistics Module, Z-Score and F-Score
NAS:VCRE Key Ratios
| Market Cap $ M | 351.88 |
| Enterprise Value $ M | 256.17 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.63 |
| Price/Sales | 733.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.05 |
| Beneish M-Score | -2.82 |
| 10-y EBITDA Growth Rate % | -19.10 |
| 5-y EBITDA Growth Rate % | 13.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.48 |
| EV-to-EBITDA | -4.48 |
| PEG | -- |
| Shares Outstanding M | 28.15 |
| Net Margin (%) | -12,569.76 |
| Operating Margin % | -13,110.14 |
| Pre-tax Margin (%) | -12,563.27 |
| Quick Ratio | 12.68 |
| Current Ratio | 12.68 |
| ROA % (ttm) | -49.52 |
| ROE % (ttm) | -54.02 |
| ROIC % (ttm) | -945.57 |
| Dividend Yield % | -- |
| Altman Z-Score | 23.74 |
VCRE Number of Guru Trades
VCRE Volume of Guru Trades
Gurus Latest Trades with NAS:VCRE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VCRE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vicore Pharma Holding AB Insider Transactions
No Available Data
News about NAS:VCRE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers